| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
01/01/2020 - 06/30/2020
|
|
Authorizing Officer name
|
Martin
G.
Corry
|
|
Title
|
Principal
|
|
Business name
|
Corry Associates, LLC
|
|
Address
|
6 Beacon Street
Suite 312
|
|
City, state, zip code
|
Boston, MA 02108
|
|
Country
|
USA
|
|
Phone
|
617-227-2345
|
|
|
|
|
Client Compensation
|
| Harness Horseman's Association of New England |
$30,000.00
|
| Coalition of Families and Advocates- COFAR |
$0.00
|
| Cape Cod Chamber of Commerce |
$20,000.00
|
| Massachusetts State Automobile Dealers Association |
$18,000.00
|
| Beer Distributors of Massachusetts, Inc. |
$85,000.00
|
| Massachusetts Nurses Association |
$52,500.00
|
| Sanofi US, Inc. |
$31,250.00
|
| Motion Picture Association, Inc. |
$97,910.03
|
| AstraZeneca Pharmaceuticals LP |
$100,000.00
|
| Magazine Publishers of America – The Association of Magazine Media |
$0.00
|
| Massachusetts Visitor Industry Council |
$20,000.00
|
| L. Knife & Son, Inc. |
$10,000.00
|
| Total salaries received |
$464,660.03
|
|
|
| |
|
Compensation/Salaries Paid
|
|
Martin G. Corry
|
$180,000.00
|
|
Charles Stefanini
|
$60,000.00
|
|
Dominique Demar
|
$40,000.00
|
| Total salaries paid |
$280,000.00
|
|
| |
|
Activities, Bill Numbers and Titles
|
| No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
| |
|
Operating Expenses
|
| 01/01/2020 |
Verizon
|
Telephone, cell phone, handheld
|
$1,870.00
|
| 01/01/2020 |
AMB Consulting
|
Other operating expenses
|
$2,000.00
|
| | | Total operating expenses |
$3,870.00
|
|
| |
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
| |
|
Lobbyist: Charles Stefanini
|
|
Client:
AstraZeneca Pharmaceuticals LP
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s Health Policy Commission (HPC) as a formal member of the Health Policy Commission’s (HPC) Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224).
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Participate in public meetings/discussions pertaining to drug costs (net and gross), value-based contracts with MassHealth, health plans and the HPC, potential drug company testimony at the annual HPC Cost Trends Hearings.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1853
|
An Act relative to fail first and patient safety
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Interactions with HPC Board Members (Commissioners), HPC Staff to include Executive Director, and the staff from the Center of Health Information Analysis (CHIA). Planning and executing executive & legislative tours at research & development laboratory/campus in the Commonwealth of MA in Waltham.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
926
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
898
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of Prescription Drug coupons, co-pay assistance/vouchers.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
969
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Amendment#654 to the senate budget; MassHealth supplemental rebates. Interactions with the Health Policy Commission and participation in the HPC Advisory Council to include value-based agreements with MassHealth and in the Commonwealth.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3481
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1167
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4641
|
An Act relative to the availability of prescription medication during an emergency
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
561
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
915
|
An Act ensuring access to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
949
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1154
|
An Act to reduce drug costs through transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4638
|
An Act providing for diabetes management in schools
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1235
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Advocated for FY19 Supplemental Budget specifically Section 15, Section 226 of Chapter 139 of the acts of 2012 which stipulated an extension of the sunset of the Massachusetts patient assistance programs (drug coupons). Amendment#637; Pharmaceutical co-pay assistance.
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
614
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1630
|
An Act relative to pharmaceutical price transparency and cost sharing.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
683
|
An Act establishing medicare for all in Massachusetts
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
717
|
An Act to create a special commission to improve transparency and affordability at the Group Insurance Commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1799
|
An Act to ensure prescription drug cost transparency and affordability.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1194
|
An Act establishing Medicare for all in Massachusetts
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1301
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1481
|
An Act to promote transparency and cost control of pharmaceutical drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2974
|
An Act establishing Medicare for All in MA.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1295
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3249
|
An Act relative to promoting transparency in the pharmaceutical industry.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1168
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act Relative to Pharmaceutical Access, Cost and Transparency.
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3067
|
An Act to reduce drug costs through transparency.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1177
|
An Act relative to protecting health care consumers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
552
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2969
|
AN Act providing for the establishment of a drug cost review commission.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1186
|
An Act strengthening HPC and CHIA market oversight
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
695
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2655
|
An Act to promote transparency of cost controls of pharmaceutical prices.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1933
|
An Act to improve patient access to cancer clinical trial programs
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1352
|
An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
949
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
966
|
An Act to promote value-based insurance design in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1099
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
629
|
An Act relative to pharmaceutical pricing
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2145
|
AN Act relative to prescription drug price transparency.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
652
|
An Act relative to pharmaceutical "gag clauses"
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1117
|
An Act relative to drug prices paid by carriers
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
703
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
771
|
An Act to promote transparency in prescription drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
733
|
An Act relative to consumer protection for prescription drug purchases
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
2059
|
An Act to prevent transparency and prevent drug price gouging.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act advancing and expanding access to telemedicine services
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
112
|
An Act regarding MA drug price relief.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
611
|
An Act to promote value-based insurance design in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act relative to pharmaceutical price transparency and cost sharing
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3442
|
An Act to ensure prescription drug cost transparency and affordability.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1013
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act Relative to Pharmaceutical Access, Cost and Transparency.
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1701
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
931
|
An Act promoting high value and high quality care
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
653
|
An Act relative to prescription drug pricing
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1304
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1767
|
An Act to promote prescription drug prices.
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Charles Stefanini
|
|
Client:
Massachusetts Visitor Industry Council
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2951
|
An Act relative to tourism and visitation marketing and promotion grants
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2952
|
An Act relative to investments in tourism and visitation marketing and promotion
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Harness Horseman's Association of New England
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
322
|
An Act to promote horse racing in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
145
|
An Act further regulating thoroughbred breeding
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
13
|
An Act relative to horse racing and wagering
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Coalition of Families and Advocates- COFAR
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
73
|
An Act to increase the safety of individuals with disabilities relying on life-support equipment
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1503
|
An Act further regulating the appointment of certain guardians
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1415
|
An Act further regulating the appointment of certain guardians
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
88
|
An Act relative to community based day support services
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
93
|
An Act regarding transparency for individuals and guardians
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
125
|
An Act establishing an independent office of quality assurance
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Cape Cod Chamber of Commerce
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Other
|
No activity to report this period.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Massachusetts State Automobile Dealers Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
282
|
An Act relative to clarification of the Massachusetts franchise law
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
658
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2133
|
An Act relative to temporary registration plates
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3031
|
An Act relative to temporary registration plates
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
234
|
An Act relative to the issuance of a Class 1 dealer license
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3558
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
172
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
576
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
179
|
An Act to address inequality, promote opportunity, and end poverty
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
629
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
206
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
262
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3049
|
An Act relative to temporary dealer plates
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1087
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
960
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Beer Distributors of Massachusetts, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
212
|
An Act further regulating storage of alcoholic beverages
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
327
|
An Act relative to craft brewers
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
104
|
An Act relative to Craft Brewers
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Water Resources Authority (MWRA)
|
Conversations with MWRA regarding abatement of beer in May of 2020
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3549
|
An Act to promote economic development and market access for emerging businesses
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
178
|
An Act to promote economic development and market access for emerging businesses
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Massachusetts Nurses Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
838
|
An Act strengthening the penalty for assault or assault and battery on emergency medical technician, ambulance operator, ambulance attendant or health care provider
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2602
|
An Act relative to emergency hazard health duty
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1139
|
An Act relative to the closing of hospital essential services
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to hospital profit and fairness
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Reopening guidelines for healthcare facilities
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1427
|
An Act requiring healthcare employers to develop and implement programs to prevent workplace violence
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1720
|
An Act relative to creating a pilot program to transfer high acuity behavioral health and dual diagnosis patients away from overcrowded emergency departments
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Proposed closure of mental health units at Providence Hospital
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
672
|
An Act relative to the closing of hospital essential services
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2311
|
An Act relative to credible service for school nurses
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Falmouth Hospital Maternity Closure
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1866
|
An Act to ensure safe medication administration
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4739
|
An Act creating a presumption of relatedness for essential workers suffering from COVID-19
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1340
|
An Act relative to liability protection for disaster volunteers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
365
|
An Act authorizing the option of providing basic common sense health services for residents of assisted living residences
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Proposed closure at Leonard Morse/MetroWest Medical Center
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1255
|
An Act relative to workforce development and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1939
|
An Act relative to home health and hospice aides
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2769
|
AN Act Putting Patients First
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1416
|
An Act requiring health care employers to develop and implement programs to prevent workplace violence
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1163
|
An Act relative to creating intensive stabilization and treatment units within the Department of Mental Health
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Proposed closure of Somerville ED
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
3487
|
An Act relative to safe patient handling in certain health facilities
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1164
|
An Act relative to creating a pilot program to transfer high acuity behavioral health and dual diagnosis patients away from overcrowded emergency departments
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
COVID Response at various hositals
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
103
|
An Act relative to nurse licensure compacts
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1976
|
An Act requiring health care facilities to develop and implement programs to prevent workplace violence
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Temporary closure of ICUs at Nashoba Valley Medical Center
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1213
|
An Act relative to safe patient handling in certain health facilities
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1144
|
An Act relative to hospital profit transparency and fairness
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Commonwealth COVID-19 response (testing, shelter in place, masking, etc)
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1888
|
An Act relating to liability protection for disaster volunteers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1093
|
An Act requiring health care facilities to develop and implement programs to prevent workplace violence
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Temporary closure of ICUS at Holy Family Hosital
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1578
|
An Act strengthening the penalty for assault or assault and battery on an emergency medical technician, ambulance operator, ambulance attendant or health care provider
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4611
|
An Act relative to emergency hazard health duty
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Department of Public Health (DPH)
|
Meetings with local electeds; DPH hearing; outreach to Baker Administration
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1328
|
An Act to ensure safe medication administration
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4749
|
An Act providing worker compensation protection to emergency response and medical personnel related to COVID-19 infection
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1944
|
An Act relative to nurse licensure compact in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
668
|
An Act improving fiscal transparency
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Cambridge Health Alliance contract negotiations
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2004
|
An Act relative to workforce development and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1719
|
An Act relative to creating intensive stabilization and treatment units within the Department of Mental Health
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2546
|
An Act addressing barriers to care for mental health
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Sanofi US, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Motion Picture Association, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
2419
|
An Act to remove the film tax credit expiration date
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2627
|
An Act relative to film tax credit transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1728
|
An Act supporting job growth in the commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2629
|
An Act relative to the film tax credit
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
AstraZeneca Pharmaceuticals LP
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions with the HPC and/or Advisory Council and CHIA with a focus on health care price variation, gross and net prescription drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO’s).
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
614
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
717
|
An Act to create a special commission to improve transparency and affordability at the Group Insurance Commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1799
|
An Act to ensure prescription drug cost transparency and affordability.
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2974
|
An Act establishing Medicare for All in MA.
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of Prescription Drug coupons, co-pay assistance/vouchers.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
949
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act Relative to Pharmaceutical Access, Cost and Transparency.
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3607
|
An Act to reduce drug costs through transparency.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1177
|
An Act relative to protecting health care consumers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
915
|
An Act ensuring access to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
949
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
966
|
An Act to promote value-based insurance design in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Advocated for FY19 Supplemental Budget specifically Section 15, Section 226 of Chapter 139 of the acts of 2012 which stipulated an extension of the sunset of the Massachusetts patient assistance programs (drug coupons). Amendment#637; Pharmaceutical co-pay assistance.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
969
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1154
|
An Act to reduce drug costs through transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
552
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2969
|
AN Act providing for the establishment of a drug cost review commission.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1186
|
An Act strengthening HPC and CHIA market oversight
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Interactions with HPC Board Members (Commissioners), HPC Staff to include Executive Director, and the staff from the Center of Health Information Analysis (CHIA). Planning and executing executive & legislative tours at research & development laboratory/campus in the Commonwealth of MA in Waltham.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1630
|
An Act relative to pharmaceutical price transparency and cost sharing.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1194
|
An Act establishing Medicare for all in Massachusetts
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3481
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
112
|
An Act regarding MA drug price relief.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
611
|
An Act to promote value-based insurance design in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4641
|
An Act relative to the availability of prescription medication during an emergency
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
561
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
653
|
An Act relative to prescription drug pricing
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1304
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1767
|
An Act to promote prescription drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
898
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1701
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
931
|
An Act promoting high value and high quality care
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act relative to pharmaceutical price transparency and cost sharing
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3442
|
An Act to ensure prescription drug cost transparency and affordability.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1013
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Participate in public meetings/discussions pertaining to drug costs (net and gross), value-based contracts with MassHealth, health plans and the HPC, potential drug company testimony at the annual HPC Cost Trends Hearings.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1853
|
An Act relative to fail first and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
629
|
An Act relative to pharmaceutical pricing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
696
|
An Act providing disclosure of political phone calls
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2145
|
AN Act relative to prescription drug price transparency.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
652
|
An Act relative to pharmaceutical "gag clauses"
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
926
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1295
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3249
|
An Act relative to promoting transparency in the pharmaceutical industry.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1168
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1117
|
An Act relative to drug prices paid by carriers
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
703
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
771
|
An Act to promote transparency in prescription drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
733
|
An Act relative to consumer protection for prescription drug purchases
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s Health Policy Commission (HPC) as a formal member of the Health Policy Commission’s (HPC) Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224).
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1167
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
2059
|
An Act to prevent transparency and prevent drug price gouging.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act advancing and expanding access to telemedicine services
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4638
|
An Act providing for diabetes management in schools
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1235
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1301
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1481
|
An Act to promote transparency and cost control of pharmaceutical drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
683
|
An Act establishing medicare for all in Massachusetts
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Amendment#654 to the senate budget; MassHealth supplemental rebates. Interactions with the Health Policy Commission and participation in the HPC Advisory Council to include value-based agreements with MassHealth and in the Commonwealth.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1099
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
695
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2655
|
An Act to promote transparency of cost controls of pharmaceutical prices.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1933
|
An Act to improve patient access to cancer clinical trial programs
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act Relative to Pharmaceutical Access, Cost and Transparency.
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1352
|
An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Magazine Publishers of America – The Association of Magazine Media
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
261
|
An Act to prohibit negative option sales and disclosure of financial and personal information without a consumer’s express agreement
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
Massachusetts Visitor Industry Council
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
2951
|
An Act relative to tourism and visitation marketing and promotion grants
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2952
|
An Act relative to investments in tourism and visitation marketing and promotion
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Demar
|
|
Client:
L. Knife & Son, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Other
|
No activity to report this period.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Harness Horseman's Association of New England
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
322
|
An Act to promote horse racing in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
145
|
An Act further regulating thoroughbred breeding
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
13
|
An Act relative to horse racing and wagering
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Coalition of Families and Advocates- COFAR
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1503
|
An Act further regulating the appointment of certain guardians
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
88
|
An Act relative to community based day support services
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
125
|
An Act establishing an independent office of quality assurance
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
73
|
An Act to increase the safety of individuals with disabilities relying on life-support equipment
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1415
|
An Act further regulating the appointment of certain guardians
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
93
|
An Act regarding transparency for individuals and guardians
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Cape Cod Chamber of Commerce
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Other
|
No activity to report this period.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Massachusetts State Automobile Dealers Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
262
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
629
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
172
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
658
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
282
|
An Act relative to clarification of the Massachusetts franchise law
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
206
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3049
|
An Act relative to temporary dealer plates
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
960
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2133
|
An Act relative to temporary registration plates
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1087
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
576
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
179
|
An Act to address inequality, promote opportunity, and end poverty
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
234
|
An Act relative to the issuance of a Class 1 dealer license
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3031
|
An Act relative to temporary registration plates
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3558
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Beer Distributors of Massachusetts, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
212
|
An Act further regulating storage of alcoholic beverages
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
178
|
An Act to promote economic development and market access for emerging businesses
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3549
|
An Act to promote economic development and market access for emerging businesses
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
104
|
An Act relative to Craft Brewers
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Water Resources Authority (MWRA)
|
Conversations with MWRA regarding abatement of beer in May of 2020.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
327
|
An Act relative to craft brewers
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Massachusetts Nurses Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1888
|
An Act relating to liability protection for disaster volunteers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1093
|
An Act requiring health care facilities to develop and implement programs to prevent workplace violence
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Temporary closure of ICUS at Holy Family Hosital
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1427
|
An Act requiring healthcare employers to develop and implement programs to prevent workplace violence
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1720
|
An Act relative to creating a pilot program to transfer high acuity behavioral health and dual diagnosis patients away from overcrowded emergency departments
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Proposed closure of mental health units at Providence Hospital
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1255
|
An Act relative to workforce development and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1939
|
An Act relative to home health and hospice aides
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2769
|
AN Act Putting Patients First
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3487
|
An Act relative to safe patient handling in certain health facilities
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1164
|
An Act relative to creating a pilot program to transfer high acuity behavioral health and dual diagnosis patients away from overcrowded emergency departments
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
COVID Response at various hositals
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1340
|
An Act relative to liability protection for disaster volunteers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
365
|
An Act authorizing the option of providing basic common sense health services for residents of assisted living residences
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Proposed closure at Leonard Morse/MetroWest Medical Center
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1944
|
An Act relative to nurse licensure compact in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
668
|
An Act improving fiscal transparency
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Cambridge Health Alliance contract negotiations
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
838
|
An Act strengthening the penalty for assault or assault and battery on emergency medical technician, ambulance operator, ambulance attendant or health care provider
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2602
|
An Act relative to emergency hazard health duty
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1328
|
An Act to ensure safe medication administration
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4749
|
An Act providing worker compensation protection to emergency response and medical personnel related to COVID-19 infection
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2004
|
An Act relative to workforce development and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1719
|
An Act relative to creating intensive stabilization and treatment units within the Department of Mental Health
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2546
|
An Act addressing barriers to care for mental health
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1139
|
An Act relative to the closing of hospital essential services
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to hospital profit and fairness
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Reopening guidelines for healthcare facilities
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1416
|
An Act requiring health care employers to develop and implement programs to prevent workplace violence
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1163
|
An Act relative to creating intensive stabilization and treatment units within the Department of Mental Health
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Proposed closure of Somerville ED
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
672
|
An Act relative to the closing of hospital essential services
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2311
|
An Act relative to credible service for school nurses
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Falmouth Hospital Maternity Closure
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
103
|
An Act relative to nurse licensure compacts
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1976
|
An Act requiring health care facilities to develop and implement programs to prevent workplace violence
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Temporary closure of ICUs at Nashoba Valley Medical Center
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1578
|
An Act strengthening the penalty for assault or assault and battery on an emergency medical technician, ambulance operator, ambulance attendant or health care provider
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4611
|
An Act relative to emergency hazard health duty
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Department of Public Health (DPH)
|
Meetings with local electeds; DPH hearing; outreach to Baker Administration
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1213
|
An Act relative to safe patient handling in certain health facilities
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1144
|
An Act relative to hospital profit transparency and fairness
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Commonwealth COVID-19 response (testing, shelter in place, masking, etc)
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1866
|
An Act to ensure safe medication administration
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4739
|
An Act creating a presumption of relatedness for essential workers suffering from COVID-19
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Sanofi US, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Motion Picture Association, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
2629
|
An Act relative to the film tax credit
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2627
|
An Act relative to film tax credit transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1728
|
An Act supporting job growth in the commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2419
|
An Act to remove the film tax credit expiration date
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
AstraZeneca Pharmaceuticals LP
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Amendment#654 to the senate budget; MassHealth supplemental rebates. Interactions with the Health Policy Commission and participation in the HPC Advisory Council to include value-based agreements with MassHealth and in the Commonwealth.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1099
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
552
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2969
|
AN Act providing for the establishment of a drug cost review commission.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1186
|
An Act relative to the Burncoat Pond Watershed District
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act Relative to Pharmaceutical Access, Cost and Transparency.
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
653
|
An Act relative to prescription drug pricing
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1304
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1767
|
An Act to promote prescription drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Interactions with HPC Board Members (Commissioners), HPC Staff to include Executive Director, and the staff from the Center of Health Information Analysis (CHIA). Planning and executing executive & legislative tours at research & development laboratory/campus in the Commonwealth of MA in Waltham.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
717
|
An Act to create a special commission to improve transparency and affordability at the Group Insurance Commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1799
|
An Act to ensure prescription drug cost transparency and affordability.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1194
|
An Act establishing Medicare for all in Massachusetts
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
898
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1352
|
An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Participate in public meetings/discussions pertaining to drug costs (net and gross), value-based contracts with MassHealth, health plans and the HPC, potential drug company testimony at the annual HPC Cost Trends Hearings.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
629
|
An Act relative to pharmaceutical pricing
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
695
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2655
|
An Act to promote transparency of cost controls of pharmaceutical prices.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1933
|
An Act to protect ratepayers
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of Prescription Drug coupons, co-pay assistance/vouchers.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
949
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1295
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3249
|
An Act relative to promoting transparency in the pharmaceutical industry.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1168
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3481
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
703
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
771
|
An Act to promote transparency in prescription drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
733
|
An Act relative to consumer protection for prescription drug purchases
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions with the HPC and/or Advisory Council and CHIA with a focus on health care price variation, gross and net prescription drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO’s).
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
614
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
2059
|
An Act to prevent transparency and prevent drug price gouging.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act advancing and expanding access to telemedicine services
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4638
|
An Act providing for diabetes management in schools
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1235
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1630
|
An Act relative to pharmaceutical price transparency and cost sharing.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
638
|
An Act relative to the compulsory automobile insurance limits
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
949
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
966
|
An Act to promote value-based insurance design in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4641
|
An Act relative to the availability of prescription medication during an emergency
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
561
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1301
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
N/A
|
|
Senate Docket
|
1481
|
An Act to promote transparency and cost control of pharmaceutical drug prices.
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2974
|
An act establishing medicare for all in MA
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
926
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act relative to pharmaceutical price transparency and cost sharing
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3442
|
An Act to ensure prescription drug cost transparency and affordability.
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1013
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Advocated for FY19 Supplemental Budget specifically Section 15, Section 226 of Chapter 139 of the acts of 2012 which stipulated an extension of the sunset of the Massachusetts patient assistance programs (drug coupons). Amendment#637; Pharmaceutical co-pay assistance.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
969
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1154
|
An Act to reduce drug costs through transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act Relative to Pharmaceutical Access, Cost and Transparency.
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
3067
|
An Act to reduce drug costs through transparency.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1177
|
An Act establishing the Martha's Vineyard Housing Trust
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1853
|
An Act relative to fail first and patient safety
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1117
|
An Act relative to drug prices paid by carriers
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
2145
|
AN Act relative to prescription drug price transparency.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
652
|
An Act relative to pharmaceutical "gag clauses"
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
915
|
An Act ensuring access to medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1701
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
931
|
An Act promoting high value and high quality care
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s Health Policy Commission (HPC) as a formal member of the Health Policy Commission’s (HPC) Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224).
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1167
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Docket
|
112
|
An Act regarding MA drug price relief.
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
611
|
An Act to promote value-based insurance design in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Magazine Publishers of America – The Association of Magazine Media
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
261
|
An Act to prohibit negative option sales and disclosure of financial and personal information without a consumer’s express agreement
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Massachusetts Visitor Industry Council
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2952
|
An Act relative to investments in tourism and visitation marketing and promotion
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2951
|
An Act relative to tourism and visitation marketing and promotion grants
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
L. Knife & Son, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Other
|
No activity to report this period.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 01/15/2020 | Martin G. Corry |
Adam Hinds
|
Senate
|
$200.00
|
| 02/06/2020 | Martin G. Corry |
Linda Campbell
|
Representative
|
$200.00
|
| 02/25/2020 | Martin G. Corry |
Eric Lesser
|
Senate
|
$200.00
|
| 02/25/2020 | Martin G. Corry |
Joe Boncore
|
Senate
|
$200.00
|
| 03/05/2020 | Martin G. Corry |
Jon Santiago
|
Representative
|
$200.00
|
| 03/16/2020 | Martin G. Corry |
Susan Moran
|
Senate
|
$200.00
|
| 04/22/2020 | Martin G. Corry |
Meg Kilcoyne
|
Representative
|
$200.00
|
| 05/06/2020 | Martin G. Corry |
John Lawn
|
Representative
|
$200.00
|
| | | | Total contributions |
$1,600.00
|
|
|
|
|
|